Johnson & Johnson
JNJ
#19
Rank
NZ$979.39 B
Marketcap
NZ$406.41
Share price
-2.09%
Change (1 day)
45.86%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$19.20

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$19.01. an increase over its 2024 EPS that were of NZ$11.42.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$18.8665.13%
2024NZ$11.42-53.6%
2023NZ$24.61111.16%
2022NZ$11.66-13.84%
2021NZ$13.5341.81%
2020NZ$9.54-18.92%
2019NZ$11.7721.2%
2018NZ$9.711125.3%
2017NZ$0.79-92.23%
2016NZ$10.197.37%
2015NZ$9.49-4.16%
2014NZ$9.9118.1%
2013NZ$8.3924.88%
2012NZ$6.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.56-33.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-66.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.33-66.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$39.29 106.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-81.46%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.13-41.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.49-23.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.47-34.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.43-66.17%๐Ÿ‡ฌ๐Ÿ‡ง UK